Publication

More than keratitis, ichthyosis, and deafness: Multisystem effects of lethal GJB2 mutations

Downloadable Content

Persistent URL
Last modified
  • 05/21/2025
Type of Material
Authors
    Evelyn Lilly, Harvard Medical SchoolChristopher G. Bunick, Yale UniversityAlexander M. Maley, Emory UniversityShali Zhang, Emory UniversityMary Spraker, Emory UniversityAmy J. Theos, University of Alabama BirminghamKarina L. Vivar, University of South FloridaLucia Seminario-Vidal, University of South FloridaAdam E. Bennett, University of South FloridaRobert Sidbury, University of WashingtonYasushi Ogawa, Nagoya UniversityMasashi Akiyama, Nagoya UniversityBarbara Binder, Medical University of GrazSmail Hadj-Rabia, Paris Descartes - Sorbonne Paris Cite UniversityRaffaella A. Morotti, Yale UniversityEarl J. Glusac, Yale UniversityKeith A. Choate, Yale UniversityGabriele Richard, Yale UniversityLeonard M. Milstone, Yale University
Language
  • English
Date
  • 2019-03-01
Publisher
  • MOSBY-ELSEVIER
Publication Version
Copyright Statement
  • © 2018 American Academy of Dermatology, Inc.
License
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 80
Issue
  • 3
Start Page
  • 617
End Page
  • 625
Grant/Funding Information
  • This work was supported in part by the Dermatology Foundation through a Career Development Award (to C.G.B.), an NIH/NIAMS Dermatology Training Grant to Yale T 32 AR007016 (to C.G.B. and E.L.; PI: Richard Edelson), and an NIH/NIAMS grant 5K08AR070290–02 (to C.G.B).
Abstract
  • Background: Infant death in keratitis-ichthyosis-deafness (KID) syndrome is recognized; its association with specific genotypes and pathophysiology is inadequately understood. Objective: We sought to discover characteristics that account for poor outcomes in lethal KID syndrome. Methods: We collected 4 new cases and 9 previously reported, genotyped cases of lethal KID syndrome. We performed new molecular modeling of the lethal mutants GJB2 p.A88V and GJB2 p.G45E. Results: Infant death occurred in all patients with GJB2 p.G45E and p.A88V; it is unusual with other GJB2 mutations. Early death with those 2 “lethal” mutations is likely multifactorial: during life all had ≥1 serious infection; most had poor weight gain and severe respiratory difficulties; many had additional anatomic abnormalities. Structural modeling of GJB2 p.G45E identified no impact on the salt bridge previously predicted to account for abnormal central carbon dioxide sensing of GJB2 p.A88V. Limitations: This clinical review was retrospective. Conclusion: GJB2 p.G45E and p.A88V are the only KID syndrome mutations associated with uniform early lethality. Those electrophysiologically severe mutations in GJB2 reveal abnormalities in many organs in lethal KID syndrome. All patients with KID syndrome may have subtle abnormalities beyond the eyes, ears, and skin. Early genotyping of KID syndrome births will inform prognostic discussion.
Author Notes
  • Evelyn Lilly, MD, Department of Dermatology, Massachusetts General Hospital, 50 Staniford Street, 2nd Floor, Boston, MA 02114, elilly1@mgh.harvard.edu, 617-643-8618
Keywords
Research Categories
  • Biology, Genetics
  • Health Sciences, Medicine and Surgery

Tools

Relations

In Collection:

Items